Stoxline.com

Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations

AstraZeneca PLC (AZN)

41.58   0.63 (1.54%) 06-19 14:20
Open: 41.18 Pre. Close: 40.95
High: 41.59 Low: 41.15
Volume: 1,913,661 Market Cap: 111359M

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 41.068 - 41.226 41.226 - 41.407
Low: 40.075 - 40.247 40.247 - 40.444
Close: 40.631 - 40.906 40.906 - 41.223

Technical analysis

as of: 2019-06-19 1:55:11 PM
Overall:       
Stoxline posted a BUY today, same as yesterday. Upward movement continues.
Target: Six months: 48.41     One year: 56.55
Support: Support1: 38.77    Support2: 37.12
Resistance: Resistance1: 41.45    Resistance2: 48.41
Pivot: 39.21
Moving Average: MA(5): 40.34     MA(20): 39.00
MA(100): 39.54     MA(250): 38.69
MACD: MACD(12,26): 0.58     Signal(9): 0.28
Stochastic oscillator: %K(14,3): 95.73     %D(3): 94.24
RSI: RSI(14): 70.56
52-week: High: 43.30  Low: 34.38  Change(%): 14.0
Average Vol(K): 3-Month: 482111  10-Days: 220686

Price, moving averages and Bollinger Bands

Price and moving averages has closed above its Short term moving average. Short term moving average is currently above mid-term; AND below long term moving averages. From the relationship between price and moving averages; we can see that: This stock is BULLISH in short-term; and NEUTRAL in mid-long term.
AZN has closed below upper band by 4.9%. Bollinger Bands are 38.2% wider than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.

Headline News

Mon, 17 Jun 2019 16:35:19 Z
AstraZeneca Gives Detailed Data From Calquence Leukemia Study

Fri, 14 Jun 2019 15:18:52 Z
Pharma Stock Roundup: MRK Buys Small Cancer Biotech, RHHBY, MRK Drugs Get FDA Nod

Thu, 13 Jun 2019 16:17:40 Z
Keytruda & 4 Other Reasons to Invest in Merck's (MRK) Stock

Wed, 12 Jun 2019 12:56:54 Z
Pre-Market Most Active for Jun 12, 2019 : MFG, SMFG, AZN, GSK, AMD, MDSO, NOK, TSLA, QQQ, AAT, BYND, TVIX

Mon, 10 Jun 2019 16:14:37 Z
The Zacks Analyst Blog Highlights: Bristol Myers, Merck, Roche, Lilly and AstraZeneca

Financial Analysis

Growth
Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.
Profitability
Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.
Solvency
Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.
Efficiency
Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.
Click here to get more fundamental analysis.
Tweet this page Share on Facebook
Free Technical Analysis Charts

Stock Basics & Statistics

Sector:  Healthcare
Industry:  Drug Manufacturers - Major
Shares Out. (M) 2623.55
Shares Float (M) 2623.55
% Held by Insiders
% Held by Institutions 24.50
Shares Short (K) 22276
Shares Short P. Month (K)

Stock Financials

EPS 3.460
EPS Est. Current Year 1.910
EPS Est. Next Year 1.700
EPS Est. Next Quarter 0.450
Forward EPS 1.860
Book Value (p.s.) 9.490
PEG Ratio 1.16
Profit Margin 10.41
Operating Margin 9.64
Return on Assets (ttm) 4.0
Return on Equity (ttm) 21.4
Qtrly Rev. Growth 6.0
Gross Profit (p.s.)
Sales Per Share
EBITDA (p.s.)
Qtrly Earnings Growth 74.40
Operating Cash Flow (M) 2370.00
Levered Free Cash Flow (M) 6290.00

Stock Valuations

P/E 11.91
P/E Growth Ratio 0.01
P/BV 4.34
P/S 5919004672.00
P/CF 45.61

Dividends & Splits

Dividend 4.869
Dividend Yield 0.12
Dividend Pay Date 2019-03-27
Ex-Dividend Date 2019-02-28
Forward Dividend 1.400
Last Split Date 2015-07-27
Last Split Ratio -1e+010
7 Binary Options
Your Ad Here
android_stock_chart
Stock Chart
stoxline_lite
Stoxline Lite
stoxline_pro
Stoxline Pro
Option_Calculator
Option Calculator
(c) 2006-2019 Stoxline.com | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Stoxline.com nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Stoxline.com web site, a user agrees not to redistribute the information found therein.